title: Adiposity induced by interleukin-17A blockade.
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Iwasaki
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Yamane
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ogura
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Yasoda
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nagashima
authors.affiliation: Kyoto University, Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 54, Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: inagaki@kuhp.kyoto-u.ac.jp.
authors.forename: N
authors.initials: N
authors.lastname: Inagaki
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001786:Blood Glucose / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D005234:Fatty Liver / Q000378:metabolism; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000378:metabolism; D008875:Middle Aged; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001786:Blood Glucose; D016207:Cytokines; D006442:Glycated Hemoglobin; D020381:Interleukin-17; C508717:IL17A protein, human; C555450:secukinumab
keywords: Adiposity; Cytokine; Diabetes mellitus; Fatty liver; IL-17A; Weight gain